Treatment of Kawasaki Disease After 10 Days of Presentation

Introduction to Late Presentation Treatment

The American Heart Association recommends that IVIG should still be administered to children presenting after 10 days of fever onset if they have ongoing systemic inflammation with either persistent fever or coronary artery aneurysms 1, 2

Children presenting after day 10 of illness are candidates for IVIG treatment if they meet specific criteria, including persistent fever without alternative explanation plus elevated inflammatory markers, or coronary artery aneurysms with ongoing systemic inflammation 3, 4, 5, 1, 2
Elevated CRP >3.0 mg/dL together with either persistent fever or coronary abnormalities is also an indication for IVIG treatment 1

The American Academy of Pediatrics recommends IVIG 2 g/kg as a single infusion over 10-12 hours for the treatment of Kawasaki disease 1, 2
High-dose aspirin 80-100 mg/kg/day divided into four doses until afebrile for 48-72 hours is also recommended 3, 6

Without treatment, coronary artery abnormalities develop in 15-25% of patients; with IVIG this decreases to approximately 5% for any abnormality and 1% for giant aneurysms 3, 6
Late treatment still provides benefit when inflammation persists, with optimal treatment ideally within the first 10 days 4, 5

Inflammatory markers, such as ESR and CRP levels, should be evaluated to document ongoing inflammation before treating late presenters 3, 1, 2
Echocardiography should be performed to assess for coronary artery abnormalities 1, 2

The American Heart Association advises against withholding treatment solely based on timing if inflammation persists—the goal is preventing coronary damage, not adhering rigidly to day 10 cutoff 3, 1, 2
Incomplete Kawasaki disease is more common in infants <1 year who paradoxically have higher rates of coronary aneurysms if untreated 6

The Centers for Disease Control and Prevention recommend deferring measles and varicella immunizations for 11 months after high-dose IVIG administration 4, 2
Annual influenza vaccination is mandatory for children on long-term aspirin therapy due to Reye's syndrome risk 3, 4
The American Academy of Pediatrics advises against using ibuprofen in children taking aspirin as it antagonizes antiplatelet effects 3

The American Heart Association recommends administering IVIG 2 g/kg as a single infusion combined with high-dose aspirin (80-100 mg/kg/day divided into four doses) as early as possible within the first 10 days of fever onset, ideally within days 5-10 of illness, to reduce coronary artery aneurysm risk from 25% to less than 5% 7, 8, 9
The cornerstone of acute Kawasaki disease management is IVIG plus aspirin, which reduces coronary artery aneurysm risk from 25% to less than 5%, with a dose of 2 g/kg as a single infusion over 10-12 hours 9

Approximately 10-20% of patients develop persistent or recrudescent fever ≥36 hours after completing initial IVIG infusion, and the American College of Cardiology recommends administering a second dose of IVIG 2 g/kg as a single infusion 7, 8, 10
For IVIG-resistant cases, the American Heart Association suggests using methylprednisolone (20-30 mg/kg IV for 3 days) or infliximab (5 mg/kg IV over 2 hours) as second-line options, with similar efficacy 7, 8, 10

The American College of Cardiology recommends low-dose aspirin (3-5 mg/kg/day) until 6-8 weeks after disease onset for patients with no coronary abnormalities, and indefinitely for those with small coronary aneurysms 7, 8
For patients with moderate aneurysms (4-6 mm), the American Heart Association suggests low-dose aspirin plus a second antiplatelet agent (clopidogrel 1 mg/kg/day, max 75 mg/day) 7
For patients with giant aneurysms (≥8 mm), the American College of Cardiology recommends low-dose aspirin plus warfarin (target INR 2.0-2.5) or alternative therapies such as aspirin plus therapeutic low-molecular-weight heparin 7, 8, 11

The American Academy of Pediatrics recommends frequent echocardiography and ECG during the first 3 months after diagnosis, especially for giant aneurysms, with the highest thrombosis risk occurring within the first 3 months, peaking at days 15-45 7, 8

The American Academy of Pediatrics advises deferring measles and varicella immunizations for 11 months after high-dose IVIG, and annual influenza vaccination is mandatory for children on long-term aspirin therapy 7, 8, 9
The American Heart Association warns against using ibuprofen in children taking aspirin for antiplatelet effects, as it antagonizes irreversible platelet inhibition 7